Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Retained Earnings (2016 - 2026)

Wave Life Sciences (WVE) has disclosed Retained Earnings for 12 consecutive years, with -$1.4 billion as the latest value for Q1 2026.

  • For Q1 2026, Retained Earnings fell 15.71% year-over-year to -$1.4 billion; the TTM value through Mar 2026 reached -$1.4 billion, down 15.71%, while the annual FY2025 figure was -$250000.0, 4.58% up from the prior year.
  • Retained Earnings hit -$1.4 billion in Q1 2026 for Wave Life Sciences, down from -$250000.0 in the prior quarter.
  • Across five years, Retained Earnings topped out at $95000.0 in Q1 2022 and bottomed at -$1.4 billion in Q1 2026.
  • Average Retained Earnings over 5 years is -$459.2 million, with a median of -$250000.0 recorded in 2025.
  • Year-over-year, Retained Earnings soared 100.01% in 2022 and then plummeted 1047196.84% in 2023.
  • Wave Life Sciences' Retained Earnings stood at -$29000.0 in 2022, then crashed by 327.59% to -$124000.0 in 2023, then crashed by 111.29% to -$262000.0 in 2024, then increased by 4.58% to -$250000.0 in 2025, then crashed by 540829.2% to -$1.4 billion in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$1.4 billion, -$250000.0, and -$190000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.